CIS: Market for Medicaments Containing Insulin But Not Antibiotics In Measured Doses 2024

Market Size for Medicaments Containing Insulin But Not Antibiotics In Measured Doses in CIS

The CIS prophylactic medicaments containing insulin market reached $X in 2022, increasing by 3.1% against the previous year. The market value increased at an average annual rate of +1.2% over the period from 2012 to 2022; however, the trend pattern indicated some noticeable fluctuations being recorded throughout the analyzed period. As a result, consumption reached the peak level of $X. From 2016 to 2022, the growth of the market remained at a somewhat lower figure.

Production of Medicaments Containing Insulin But Not Antibiotics In Measured Doses in CIS

In value terms, prophylactic medicaments containing insulin production expanded modestly to $X in 2022 estimated in export price. Overall, production, however, showed a relatively flat trend pattern. The most prominent rate of growth was recorded in 2015 when the production volume increased by 28% against the previous year. As a result, production attained the peak level of $X. From 2016 to 2022, production growth remained at a lower figure.

Exports of Medicaments Containing Insulin But Not Antibiotics In Measured Doses

Exports in CIS

Prophylactic medicaments containing insulin exports soared to X tons in 2022, jumping by 47% on 2021. Overall, exports continue to indicate significant growth. The pace of growth appeared the most rapid in 2018 when exports increased by 1,546% against the previous year. The volume of export peaked in 2022 and is likely to see steady growth in years to come.

In value terms, prophylactic medicaments containing insulin exports dropped notably to $X in 2022. Over the period under review, exports showed a significant expansion. The most prominent rate of growth was recorded in 2018 when exports increased by 2,120% against the previous year. As a result, the exports reached the peak of $X. From 2019 to 2022, the growth of the exports failed to regain momentum.

Exports by Country

In 2022, Russia (X tons) was the major exporter of medicaments containing insulin but not antibiotics in measured doses in the CIS, constituting 100% of total export.

Russia was also the fastest-growing in terms of the medicaments containing insulin but not antibiotics in measured doses exports, with a CAGR of +104.2% from 2012 to 2022. While the share of Russia (+96 p.p.) increased significantly, the shares of the other countries remained relatively stable throughout the analyzed period.

In value terms, Russia ($X) also remains the largest prophylactic medicaments containing insulin supplier in the CIS.

From 2012 to 2022, the average annual rate of growth in terms of value in Russia totaled +85.4%.

Export Prices by Country

In 2022, the export price in the CIS amounted to $X per ton, declining by -43.8% against the previous year. Over the period under review, the export price showed a abrupt slump. The pace of growth was the most pronounced in 2020 an increase of 74% against the previous year. As a result, the export price attained the peak level of $X per ton. From 2021 to 2022, the export prices remained at a lower figure.

As there is only one major export destination, the average price level is determined by prices for Russia.

From 2012 to 2022, the rate of growth in terms of prices for Russia amounted to -9.2% per year.

Imports of Medicaments Containing Insulin But Not Antibiotics In Measured Doses

Imports in CIS

Prophylactic medicaments containing insulin imports amounted to X tons in 2022, picking up by 4.1% against the previous year's figure. The total import volume increased at an average annual rate of +2.9% from 2012 to 2022; however, the trend pattern indicated some noticeable fluctuations being recorded throughout the analyzed period. The growth pace was the most rapid in 2013 when imports increased by 41%. The volume of import peaked at X tons in 2019; however, from 2020 to 2022, imports remained at a lower figure.

In value terms, prophylactic medicaments containing insulin imports shrank modestly to $X in 2022. In general, imports, however, continue to indicate a deep slump. The pace of growth appeared the most rapid in 2021 with an increase of 32% against the previous year. Over the period under review, imports attained the maximum at $X in 2013; however, from 2014 to 2022, imports remained at a lower figure.

Imports by Country

Russia was the key importer of medicaments containing insulin but not antibiotics in measured doses in the CIS, with the volume of imports amounting to X tons, which was approx. 60% of total imports in 2022. Kazakhstan (X tons) ranks second in terms of the total imports with a 19% share, followed by Azerbaijan (6.9%) and Uzbekistan (5.4%). Belarus (X tons) and Moldova (X tons) followed a long way behind the leaders.

Russia experienced a relatively flat trend pattern with regard to volume of imports of medicaments containing insulin but not antibiotics in measured doses. At the same time, Azerbaijan (+58.5%), Belarus (+11.9%), Kazakhstan (+10.2%), Uzbekistan (+8.3%) and Moldova (+5.4%) displayed positive paces of growth. Moreover, Azerbaijan emerged as the fastest-growing importer imported in the CIS, with a CAGR of +58.5% from 2012-2022. From 2012 to 2022, the share of Kazakhstan, Azerbaijan, Uzbekistan and Belarus increased by +9.6, +6.8, +5.4 and +2.3 percentage points, respectively. The shares of the other countries remained relatively stable throughout the analyzed period.

In value terms, Russia ($X), Kazakhstan ($X) and Azerbaijan ($X) were the countries with the highest levels of imports in 2022, with a combined 86% share of total imports.

Azerbaijan, with a CAGR of +74.4%, saw the highest growth rate of the value of imports, among the main importing countries over the period under review, while purchases for the other leaders experienced more modest paces of growth.

Import Prices by Country

In 2022, the import price in the CIS amounted to $X per ton, with a decrease of -5.5% against the previous year. Over the period under review, the import price saw a abrupt curtailment. The most prominent rate of growth was recorded in 2021 when the import price increased by 14%. The level of import peaked at $X per ton in 2012; however, from 2013 to 2022, import prices remained at a lower figure.

Prices varied noticeably by country of destination: amid the top importers, the country with the highest price was Moldova ($X per ton), while Uzbekistan ($X per ton) was amongst the lowest.

From 2012 to 2022, the most notable rate of growth in terms of prices was attained by Azerbaijan (+10.0%), while the other leaders experienced mixed trends in the import price figures.

Source: IndexBox Platform

Frequently Asked Questions (FAQ) :